IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Shanghai Yunying Medical Technology
Jules Bordet Institute
SpeciCare
MultiVir, Inc.
Merrimack Pharmaceuticals
Optimata Ltd.